BCIQ Profiles

Company Profile Report

Patient groups urge CVS to reconsider ICER-restricted formulary

At least 94 patient groups and individuals signed a letter urging CVS Health Corp. (NYSE:CVS) President and CEO Larry Merlo to reconsider a new formulary that would be

Read the full 286 word article

How to gain access

Continue reading with a
two-week free trial.